Polaryx Therapeutics Common Stock Net Tangible Assets

Polaryx Therapeutics Common Stock (PLYX) currently reports a net tangible assets of $11M as of June 2026. That compares with $3.2M in the prior-year period — up 236.9% year over year. Use the charts on this page to explore Polaryx Therapeutics Common Stock's net tangible assets history and peer comparisons.

Polaryx Therapeutics Common Stock's net tangible assets increased from $3.2M to $11M — a 236.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Polaryx Therapeutics Common Stock reported $11M in net tangible assets as of June 2026. That compares with $3.2M in the prior-year period — up 236.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Polaryx Therapeutics Common Stock, and consider following PLYX for alerts when major investors trade the stock.

Polaryx Therapeutics Common Stock is classified in the Healthcare sector. On net tangible assets, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLYX with unrelated industries.